Unknown

Dataset Information

0

Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).


ABSTRACT: We assessed trends in treatment of patients with CRE from 2012 through 2018. We detected decreased utilization of aminoglycosides and colistin and increased utilization in extended-spectrum cephalosporins and ceftazidime-avibactam. We found significant uptake of ceftazidime-avibactam, a newly approved antibiotic, to treat CRE infections.

SUBMITTER: Suda KJ 

PROVIDER: S-EPMC10466386 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).

Suda Katie J KJ   Traversa Alfredo A   Patel Ursula U   Poggensee Linda L   Fitzpatrick Margaret A MA   Wilson Geneva M GM   Evans Charlesnika T CT  

Infection control and hospital epidemiology 20211124 4


We assessed trends in treatment of patients with CRE from 2012 through 2018. We detected decreased utilization of aminoglycosides and colistin and increased utilization in extended-spectrum cephalosporins and ceftazidime-avibactam. We found significant uptake of ceftazidime-avibactam, a newly approved antibiotic, to treat CRE infections. ...[more]

Similar Datasets

| PRJNA1102395 | ENA
| S-EPMC8775193 | biostudies-literature
| S-EPMC9726513 | biostudies-literature
| S-EPMC8557067 | biostudies-literature
| S-EPMC9596539 | biostudies-literature
| S-EPMC9989732 | biostudies-literature
| S-EPMC9525088 | biostudies-literature
| S-EPMC7029447 | biostudies-literature
| S-EPMC11320313 | biostudies-literature
| S-EPMC11532984 | biostudies-literature